Income statement of PolyPeptide Group AG

1 January–31 December

kCHF

Note

2025

2024

 

 

 

 

Financial income

7

9,790

16,720

Service income

 

-395

9,603

Total income

 

9,395

26,323

 

 

 

 

Personnel expenses

 

-9,204

-5,767

Other operating expenses

 

-3,182

-2,284

Interest expenses third parties

 

-3,468

-3,003

Interest expenses related parties

 

-1,240

-2,804

Other financial expenses

8

-3,033

-2,689

Depreciation on tangible assets

 

-96

-404

Impairment loss/reversal on investments

9

-695,962

326,400

Operating result before taxes (EBT)

 

-706,790

335,772

 

 

 

 

Taxes

 

Net loss/profit for the year

 

-706,790

335,772